Christopher DelOrefice to Join BD as Chief Financial Officer
FRANKLIN LAKES, N.J., Aug. 11, 2021 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher DelOrefice has been named executive vice president and chief financial officer (CFO), effective Sept. 6, 2021.
- FRANKLIN LAKES, N.J., Aug. 11, 2021 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher DelOrefice has been named executive vice president and chief financial officer (CFO), effective Sept. 6, 2021.
- DelOrefice succeeds Christopher Reidy, 64, who announced his intent to retire from BD last week.
- DelOrefice, 50, will join BD from Johnson & Johnson (J&J), where he is currently vice president of Investor Relations.
- For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .